CTN :40509091
12 Jun, 2025
NA
Tender For re-tender for the procurement of specialty drugs for the year 2025-26 - adenosine inj ip 3 mg/ml, amphotericin b inj ip 50 mg/ml, ampicillin and sulbactam for inj each vial contains ampicillin 1 g and sulbactam 0.5 g, artesunate +(sulphadoxine + pyremethamine) each combi blister pack contains; [3 tablets of artesunate (each 200 mg) and 2 tablets of sulphadoxine + pyremethamine (each 750 mg + 37.5 mg)] or [3 tablets of artesunate (each 200 mg) and 3 tablets of sulphadoxine + pyremethamine (each 500 mg + 25 mg)], aztreonam inj usp 1 gm, barium sulphate suspension bp/usp 95% w/v, bethanechol chloride tab bp 25 mg, botulinum toxin a inj (freeze-dried powder for injection) 100 units, calcitriol tab 0.25 mcg, carbimazole tab ip 5 mg, cefpodoxime oral suspension ip 100 mg/5 ml, clarithromycin tab ip 500 mg, cyclosporine cap ip 100 mg, dapsone tab ip 100 mg, darifenacin tab 7.5 mg, desonide lotion 0.05%, dicumarol tab 25 mg, digoxin paediatric solution ip 50 mcg/ml, d-penicillamine cap usp 250 mg, entecavir tab ip 0.5 mg, esmolol inj ip 10 mg/ml, ethinyl oestradiol and cyproterone acetate tab 35 mcg+ 2 mg, etomidate inj usp 2 mg/ml, fexofenadine tab ip 120 mg, finasteride tab ip 5 mg, flavoxate tab ip 200 mg, flupenthixol inj ip 20 mg/ml, gadobenate dimeglumine inj 529 mg/ml, hcg (human chorionic gonadotropin) inj ip 5000 iu, an cl
ass="text-red-selected">hep
atitisan> b v
accine (rdn
a) ip 20 mcg, hy
aluronid
ase
inj ip 1500 u, hydrocortisone cre
am ip 1%, hydroxy progesterone c
apro
ate
inj ip 250 mg/ml, isopren
aline
inj ip 2 mg/ml, l
amivudine t
ab ip 100 mg, levoflox
acin infusion ip 500 mg, lignoc
aine + priloc
aine cre
am ip 2.5% + 2.5%, lignoc
aine hydrochloride topic
al solution ip 2% w/v, lignoc
aine spr
ay 10%, linezolid for or
al suspension 100 mg/5 ml, medroxy progesterone
acet
ate depot
inj 150 mg/ml, mephentermine
inj ip 30 mg/ml, methylphenid
ate t
ab 10 mg, metoprolol
inj ip 1 mg/ml, misoprostol t
ab ip 100 mcg, misoprostol t
ab ip 25 mcg, n
atur
al micronised progesterone
inj 100 mg/ml, pentoxyfylline prolonged rele
ase t
ab ip 400 mg, perfluoro-n-oct
ane liquid sterile ophth
almic prep
ar
ation, phenylephrine
inj ip 10 mg/ml, povidone iodine eye drops bp 5%, prometh
azine hydrochloride syrup ip 5 mg/5 ml, prost
agl
andin e1
inj 500 mcg, r
acec
adotril c
ap ip 100 mg, silden
afil t
ab ip 25 mg, silicon oil
inj 1000 cst, sodium nitroprusside
inj ip 50 mg, surf
act
ant (sterile intr
atr
ache
al suspension)
inj 4 ml, t
ad
al
afil t
ab ip 10 mg, tiotropium bromide inh
aler 9 mcg, tirofib
an
inj 5 mg/100 ml, tolperisone t
ab 150 mg, tolterodine t
artr
ate t
ab ip 2 mg, torsemide
inj 10 mg/ml, triclofos or
al solution ip 100 mg/ml, tryp
an blue for intr
ac
amer
al
inj 0.06% w/v, ver
ap
amil
inj ip 2.5 mg/ml, voricon
azole eye drops (lyophilized powder ) 1%